Jaro Institute Q2 FY27: revenue Rs 8,774.12 lakh, PAT Rs 1,854.14 lakh
For the quarter ended September 30, 2026, Jaro Institute reported revenue from operations of Rs 8,774.12 lakh and PAT of Rs 1,854.14 lakh versus Rs 8,040.75 lakh and Rs 1,702.00 lakh a year earlier.
Key takeaways
- Revenue from operations was Rs 8,774.12 lakh vs Rs 8,040.75 lakh a year earlier.
- Total income rose to Rs 9,018.27 lakh from Rs 8,053.67 lakh in the year-ago quarter.
- Total expenses increased to Rs 6,454.27 lakh from Rs 5,736.01 lakh a year earlier.
- PAT for the quarter was Rs 1,854.14 lakh vs Rs 1,702.00 lakh a year earlier.
- Basic EPS stood at Rs 8.48 compared with Rs 8.33 in the corresponding quarter.
Q2 FY27 · standalone
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | Rs 8,774.12 lakh | Rs 8,040.75 lakh | +9.1% |
| PAT | Rs 1,854.14 lakh | Rs 1,702.00 lakh | +9.0% |
As reported in the filing. Figures are transcribed, not computed.
What the numbers show
- Net margin was 21.13% of revenue, against 21.17% a year earlier.
- Total expenses rose 12.5% while revenue rose 9.1%.
- Other expenses accounted for Rs 604.65 lakh of the Rs 718.26 lakh rise in total expenses (84%).
- Other expenses took 43.5% of revenue, against 39.9% a year earlier.
• Revenue from operations (quarter ended September 30, 2026): Rs 8,774.12 lakh; (quarter ended September 30, 2025): Rs 8,040.75 lakh
• Other income: Rs 244.15 lakh vs Rs 12.92 lakh
• Total income: Rs 9,018.27 lakh vs Rs 8,053.67 lakh
• Employee benefits expense: Rs 2,357.09 lakh vs Rs 2,174.81 lakh
• Finance costs: Rs 30.72 lakh vs Rs 103.71 lakh
• Depreciation and amortisation expense: Rs 249.68 lakh vs Rs 245.36 lakh
• Other expenses: Rs 3,816.78 lakh vs Rs 3,212.13 lakh
• Total expenses: Rs 6,454.27 lakh vs Rs 5,736.01 lakh
• Profit before tax (PBT): Rs 2,564.00 lakh vs Rs 2,317.66 lakh
• Tax expense (total): Rs 709.86 lakh vs Rs 615.66 lakh
• Profit after tax (PAT): Rs 1,854.14 lakh vs Rs 1,702.00 lakh
• Basic EPS: Rs 8.48 vs Rs 8.33
• Diluted EPS: Rs 8.43 vs Rs 8.26
All figures above are taken from the statement of unaudited financial results for the quarter and half year ended September 30, 2026 (standalone), comparing the column "Quarter ended September 30, 2026 (Unaudited)" with the column "Quarter ended September 30, 2025 (Unaudited)".
Total income for the quarter ended September 30, 2026 stood at Rs 9,018.27 lakh, up from Rs 8,053.67 lakh in the corresponding quarter of the previous year, driven by revenue from operations of Rs 8,774.12 lakh versus Rs 8,040.75 lakh a year earlier. Other income increased to Rs 244.15 lakh from Rs 12.92 lakh. On the cost side, employee benefits expense rose to Rs 2,357.09 lakh from Rs 2,174.81 lakh, while depreciation and amortisation expense was Rs 249.68 lakh compared with Rs 245.36 lakh. Finance costs declined to Rs 30.72 lakh from Rs 103.71 lakh. Other expenses increased to Rs 3,816.78 lakh from Rs 3,212.13 lakh, taking total expenses to Rs 6,454.27 lakh against Rs 5,736.01 lakh in the year-ago quarter.
Profit before tax for the quarter was Rs 2,564.00 lakh, compared with Rs 2,317.66 lakh in the same quarter last year. Total tax expense (including current tax and deferred tax) was Rs 709.86 lakh versus Rs 615.66 lakh. Profit after tax came in at Rs 1,854.14 lakh for the quarter ended September 30, 2026, up from Rs 1,702.00 lakh a year earlier. Basic earnings per share for the quarter were reported at Rs 8.48, compared with Rs 8.33 in the corresponding previous quarter, while diluted EPS was Rs 8.43 versus Rs 8.26, as per the statement of financial results.
Track Jaro Institute of Technology Management and Research Ltd
Cruxal reads every Jaro Institute of Technology Management and Research Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.
